A detailed history of Sg Americas Securities, LLC transactions in Biomea Fusion, Inc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 15,044 shares of BMEA stock, worth $63,937. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,044
Holding current value
$63,937
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 17, 2025

BUY
$3.88 - $12.41 $58,370 - $186,696
15,044 New
15,044 $58,000
Q2 2024

Jul 12, 2024

BUY
$4.14 - $15.3 $116,271 - $429,700
28,085 Added 90.82%
59,009 $266,000
Q1 2024

May 06, 2024

BUY
$13.92 - $19.5 $430,462 - $603,018
30,924 New
30,924 $462,000

Others Institutions Holding BMEA

About Biomea Fusion, Inc.


  • Ticker BMEA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,290,600
  • Market Cap $124M
  • Description
  • Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...
More about BMEA
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.